Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Rare Diseases

Neuromuscular disorders include many rare conditions, such as Duchenne Muscular Dystrophy and Spinal Muscular Atrophy, that adversely impact respiratory health.

Tests offered

The Wal-yan Respiratory Research Centre offers a broad range of outpatient and portable tests for those affected by chronic respiratory conditions.

News & Events

Meet Embrace's new Co-Director

Embrace has appointed Professor of Clinical Psychology Jeneva Ohan as its new Co-Director alongside Professor Helen Milroy AM.

News & Events

Roadmap unveiled to support Aboriginal and Torres Strait Islander LGBTQA+ youth

Walkern Katatdjin researcher and lead author Mx Shakara Liddelow-Hunt leads a conversation with the community on the key actions to include in the Roadmap.

News & Events

Embracing World Mental Health Day

Embrace @ The Kids Research Institute Australia Senior Researcher Dr Alix Woolard and Co-Director Professor Helen Milroy.

News & Events

Embrace Big Idea 2023 winners announced

Photo (clockwise from top-left): Dr Craig Taplin, Mx Rigel Paciente, Ms Heather Roby, Dr Keely Bebbington, Dr Alix Woolard.

News & Events

Youth Sanctuary to open in Subiaco

Mental Health Minister Amber-Jade Sanderson presents funding that will enable the Youth Sanctuary to open later this year.

News & Events

Prominent WA psychiatrist receives AM award at Government House

Prominent WA psychiatrist Professor Helen Milroy receives AM award at Government House

News & Events

Study shows climate change will devastate children’s health without fast global action

Increased numbers of preterm births, higher incidence of respiratory disease and death, and more children in hospitals are some of the stark health outcomes the world is facing from the impacts of extreme climate change. 

Ivacaftor or lumacaftor/ivacaftor treatment does not alter the core CF airway epithelial gene response to rhinovirus

We tested the hypothesis that treatment of CF epithelial cells with ivacaftor (Iva) or ivacaftor/lumacaftor (Iva/Lum) would improve control of rhinovirus infection.